Axon price target raised to $308 from $296 at Barclays

Barclays analyst Tim Long raised the firm’s price target on Axon to $308 from $296 and keeps an Overweight rating on the shares. The company finished fiscal 2023 strong with another year of revenue growth over 30%, the analyst tells investors in a research note.